Biomedical Innovation
This was the first of a series of roundtable discussion by the Commerce Committee’s 21st Century Cures Initiative.
Officials from the National Institutes of Health, the Food and Drug Administration, and the University of Michigan Medical School testified … read more
Officials from the National Institutes of Health, the Food and Drug Administration, and the University of Michigan Medical School testified on the state of biomedical innovation and the search for new treatments and cures for patients. They addressed the importance of having steady funding streams and better data systems to cure diseases like cancer, Alzheimers and HIV-AIDS. Topics included pharmaceuticals, new technology, improving patient care, American competitiveness.
This was the first of a series of roundtable discussion by the Commerce Committee’s 21st Century Cures Initiative. close
People in this video
-
Jeffrey E. Shuren M.D. Director U.S. Food and Drug Administration->Center for Devices and Radiological Health
-
Janet Woodcock M.D. Director U.S. Food and Drug Administration->Center for Drug Evaluation and Research
Hosting Organization
Related Video
-
Medical Cures and Innovation
Representative Joe Pitts (R-PA) held a roundtable discussion as part of the House Energy and Commerce Committee’s 21st C…
-
Prescription Drugs and Medical Advances
Secretary Sylvia Burwell and other government and private sector health care leaders testified about ongoing medical com…
-
Cancer Research
Drs. Francis Collins and Ronald DePinho talked about the state of cancer research, the process of converting scientific …
-
Cancer Research
House Energy and Commerce Chair, Representative Fred Upton (R-MI) delivered a keynote address at a Brookings Institution…